Christopher Molineaux
About Christopher Molineaux
Christopher Molineaux serves as the Senior Vice President of Development at Calithera Biosciences, where he has worked since 2013. He has extensive experience in pharmacology and drug development, having held key positions at several pharmaceutical companies and academic institutions.
Current Role at Calithera Biosciences
Christopher Molineaux serves as the Senior Vice President of Development at Calithera Biosciences. He has held this position since 2013, contributing over a decade of experience in drug development within the biotechnology sector. His role involves overseeing the development of innovative therapies aimed at treating cancer and other serious diseases. Molineaux's leadership is integral to advancing the company's pipeline and ensuring effective collaboration across various departments.
Previous Experience at Praecis Pharmaceuticals
Molineaux worked at Praecis Pharmaceuticals as Senior Director of Pharmacology from 1994 to 2000. During his six-year tenure, he played a key role in pharmacological research and development, contributing to the advancement of therapeutic candidates. His experience at Praecis provided him with a solid foundation in drug development processes and regulatory requirements.
Research Scientist Role at Merck
Before his time at Praecis Pharmaceuticals, Molineaux was employed as a Research Scientist at Merck from 1993 to 1994. His work involved conducting research that contributed to the development of pharmaceutical products. This position allowed him to gain valuable insights into the pharmaceutical industry and the research and development lifecycle.
Academic Background in Pharmacology
Molineaux studied at the Uniformed Services University of the Health Sciences, where he focused on Pharmacology and achieved a Postdoctoral Fellowship from 1981 to 1985. Prior to this, he attended The Johns Hopkins University from 1977 to 1981. His academic training has provided him with a strong foundation in pharmacological principles and research methodologies, which he has applied throughout his career.
Experience at FibroGen and Icahn School of Medicine
Molineaux held the position of Senior Director of Development at FibroGen from 2000 to 2005, where he was involved in the development of therapeutic products. Additionally, he served as an Assistant Professor of Pharmacology at the Icahn School of Medicine at Mount Sinai from 1985 to 1991. These roles contributed to his expertise in both academic and industry settings, enhancing his capabilities in drug development and pharmacological research.